Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,602 | 15,392 | 14,086 | 13,010 | 5,670 |
| Marketable Securities | 3,053 | 3,982 | 1,052 | 4,040 | 3,570 |
| Receivables | 15,032 | 12,647 | 13,087 | 12,400 | 10,900 |
| Inventories | 22,651 | 18,509 | 16,508 | 16,340 | 15,730 |
| Other current assets | 0 | 0 | 0 | 810 | 770 |
| TOTAL | $50,444 | $52,467 | $46,217 | $46,600 | $36,640 |
| Non-Current Assets | |||||
| PPE Net | 11,537 | 11,173 | 11,599 | N/A | N/A |
| Other Non-Current Assets | 32,212 | 27,439 | 28,698 | 27,360 | 27,580 |
| TOTAL | $43,749 | $38,612 | $40,297 | $27,360 | $27,580 |
| Total Assets | $94,193 | $91,079 | $86,514 | $85,760 | $76,280 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,189 | 9,150 | 8,872 | 0 | 0 |
| Accounts payable and accrued liabilities | 3,601 | 3,651 | 3,363 | 3,710 | 2,480 |
| Accrued Expenses | 6,764 | 5,349 | 5,107 | 6,260 | 6,550 |
| Other current liabilities | 2,358 | 3,213 | 823 | 3,570 | 3,590 |
| TOTAL | $22,145 | $24,475 | $21,040 | $20,840 | $18,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,514 | 3,121 | 4,758 | 6,950 | 7,570 |
| Deferred Revenues | 967 | 1,879 | 1,675 | N/A | N/A |
| Other Non-Current Liabilities | 376 | 349 | 419 | 410 | 260 |
| TOTAL | $9,526 | $9,730 | $11,693 | $13,780 | $14,520 |
| Total Liabilities | $31,671 | $34,205 | $32,733 | $34,630 | $32,830 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,182 | 35,388 | N/A | N/A | N/A |
| Common Shares | 207 | 177 | 173 | 160 | 160 |
| Retained earnings | -100,971 | -103,733 | -105,729 | -93,560 | -95,280 |
| Other shareholders' equity | -1,421 | -1,134 | -797 | -960 | -530 |
| TOTAL | $62,522 | $56,874 | $53,781 | $51,120 | $43,450 |
| Total Liabilities And Equity | $94,193 | $91,079 | $86,514 | $85,750 | $76,280 |